MedPath

Fuzhou General Hospital

πŸ‡¨πŸ‡³China
Ownership
-
Employees
-
Market Cap
-
Website

Clonal Deletion on Living-Relative Donor Kidney Transplantation

Phase 1
Conditions
Renal Transplantation
Uremia
Interventions
Procedure: donor specific transfusion
Drug: MMF, Bortezomib
Procedure: drugs added according to the immuno condition of the recipients
First Posted Date
2011-08-03
Last Posted Date
2011-08-22
Lead Sponsor
Fuzhou General Hospital
Target Recruit Count
15
Registration Number
NCT01408797
Locations
πŸ‡¨πŸ‡³

No. 156, Xi er huan Road, Fuzhou, Fujian, China

Umbilical Mesenchymal Stem Cells and Mononuclear Cells Infusion in Type 1 Diabetes Mellitus

Phase 1
Conditions
Type 1 Diabetes Mellitus
Interventions
Biological: Umbilical mesenchymal stem cell (UC-MSCs) infusion
Drug: traditional therapy
First Posted Date
2011-06-16
Last Posted Date
2012-11-20
Lead Sponsor
Fuzhou General Hospital
Target Recruit Count
44
Registration Number
NCT01374854
Locations
πŸ‡¨πŸ‡³

Fuzhou General Hospital, Fuzhou, Fujian, China

DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma

Phase 1
Conditions
Renal Cell Carcinoma
Interventions
Drug: IL-2/IFN-Ξ±
Biological: DC-CIK
First Posted Date
2009-03-16
Last Posted Date
2011-03-08
Lead Sponsor
Fuzhou General Hospital
Target Recruit Count
100
Registration Number
NCT00862303
Locations
πŸ‡¨πŸ‡³

Fuzhou General Hospital, Fuzhou, Fujian, China

Bone Marrow Mononuclear Cell and Hyperbaric Oxygen Therapy in Diabetes Mellitus

Phase 1
Completed
Conditions
Type 2 Diabetes Mellitus
Interventions
Drug: SMT
Drug: BM-MNC+HOT
Device: HOT
First Posted Date
2008-10-07
Last Posted Date
2017-09-21
Lead Sponsor
Fuzhou General Hospital
Target Recruit Count
82
Registration Number
NCT00767260
Locations
πŸ‡¨πŸ‡³

Fuzhou General Hospital, Fuzhou, Fujian, China

Simultaneous Islet-Kidney Transplantation in Patients of Type 1 Diabetes With End-stage Renal Disease

Phase 1
Completed
Conditions
Type 1 Diabetes Mellitus
End-stage Renal Disease
Interventions
Procedure: simultaneous islet-kidney transplantation
First Posted Date
2008-06-06
Last Posted Date
2011-09-16
Lead Sponsor
Fuzhou General Hospital
Target Recruit Count
7
Registration Number
NCT00692562
Locations
πŸ‡¨πŸ‡³

Fuzhou General Hospital, Fuzhou, Fujian, China

Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Allograft Nephropathy

Phase 1
Conditions
Kidney Transplant
Chronic Allograft Nephropathy
Interventions
Biological: mesenchymal stem cell
First Posted Date
2008-04-16
Last Posted Date
2008-04-16
Lead Sponsor
Fuzhou General Hospital
Target Recruit Count
20
Registration Number
NCT00659620
Locations
πŸ‡¨πŸ‡³

Fuzhou General Hospital, Fuzhou, Fujian, China

Induction Therapy With Autologous Mesenchymal Stem Cells for Kidney Allografts

Not Applicable
Completed
Conditions
Renal Transplant Rejection
Interventions
Procedure: Kidney transplantation with MSCs infusion
Procedure: kidney transplantation without MSC infusion
First Posted Date
2008-04-14
Last Posted Date
2011-03-08
Lead Sponsor
Fuzhou General Hospital
Target Recruit Count
165
Registration Number
NCT00658073
Locations
πŸ‡¨πŸ‡³

Stem cell therapy center,Fuzhou General Hospital, Fuzhou, Fujian, China

Cotransplantation of Islet and Mesenchymal Stem Cell in Type 1 Diabetic Patients

Phase 1
Conditions
Type 1 Diabetes Mellitus
Interventions
Biological: cotransplantation of islet and mesenchymal stem cell
First Posted Date
2008-03-28
Last Posted Date
2011-06-16
Lead Sponsor
Fuzhou General Hospital
Target Recruit Count
30
Registration Number
NCT00646724
Locations
πŸ‡¨πŸ‡³

Fuzhou General Hospital, Fuzhou, Fujian, China

Β© Copyright 2025. All Rights Reserved by MedPath